Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Toxicol Appl Pharmacol ; 262(3): 341-8, 2012 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-22634334

RESUMEN

The thioredoxin system, composed of thioredoxin reductase (TrxR), thioredoxin (Trx), and NADPH, is ubiquitous in all cells and involved in many redox-dependent signaling pathways. Curcumin, a naturally occurring pigment that gives a specific yellow color in curry food, is consumed in normal diet up to 100mg per day. This molecule has also been used in traditional medicine for the treatment of a variety of diseases. Curcumin has numerous biological functions, and many of these functions are related to induction of oxidative stress. However, how curcumin elicits oxidative stress in cells is unclear. Our previous work has demonstrated the way by which curcumin interacts with recombinant TrxR1 and alters the antioxidant enzyme into a reactive oxygen species (ROS) generator in vitro. Herein we reported that curcumin can target the cytosolic/nuclear thioredoxin system to eventually elevate oxidative stress in HeLa cells. Curcumin-modified TrxR1 dose-dependently and quantitatively transfers electrons from NADPH to oxygen with the production of ROS. Also, curcumin can drastically down-regulate Trx1 protein level as well as its enzyme activity in HeLa cells, which in turn remarkably decreases intracellular free thiols, shifting the intracellular redox balance to a more oxidative state, and subsequently induces DNA oxidative damage. Furthermore, curcumin-pretreated HeLa cells are more sensitive to oxidative stress. Knockdown of TrxR1 sensitizes HeLa cells to curcumin cytotoxicity, highlighting the physiological significance of targeting TrxR1 by curcumin. Taken together, our data disclose a previously unrecognized prooxidant mechanism of curcumin in cells, and provide a deep insight in understanding how curcumin works in vivo.


Asunto(s)
Curcumina/farmacología , Células HeLa/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Tiorredoxinas/efectos de los fármacos , Ensayo Cometa , Relación Dosis-Respuesta a Droga , Células HeLa/metabolismo , Células HeLa/fisiología , Humanos , NADP/efectos de los fármacos , NADP/metabolismo , NADP/fisiología , NADPH Oxidasas/efectos de los fármacos , NADPH Oxidasas/metabolismo , NADPH Oxidasas/fisiología , Especies Reactivas de Oxígeno/metabolismo , Reductasa de Tiorredoxina-Disulfuro/efectos de los fármacos , Reductasa de Tiorredoxina-Disulfuro/metabolismo , Reductasa de Tiorredoxina-Disulfuro/fisiología , Tiorredoxinas/metabolismo , Tiorredoxinas/fisiología
2.
Life Sci ; 87(5-6): 139-46, 2010 Jul 31.
Artículo en Inglés | MEDLINE | ID: mdl-20540954

RESUMEN

AIMS: In the present work we investigated the in vitro effect of cis-4-decenoic acid, the pathognomonic metabolite of medium-chain acyl-CoA dehydrogenase deficiency, on various parameters of bioenergetic homeostasis in rat brain mitochondria. MAIN METHODS: Respiratory parameters determined by oxygen consumption were evaluated, as well as membrane potential, NAD(P)H content, swelling and cytochrome c release in mitochondrial preparations from rat brain, using glutamate plus malate or succinate as substrates. The activities of citric acid cycle enzymes were also assessed. KEY FINDINGS: cis-4-decenoic acid markedly increased state 4 respiration, whereas state 3 respiration and the respiratory control ratio were decreased. The ADP/O ratio, the mitochondrial membrane potential, the matrix NAD(P)H levels and aconitase activity were also diminished by cis-4-decenoic acid. These data indicate that this fatty acid acts as an uncoupler of oxidative phosphorylation and as a metabolic inhibitor. cis-4-decenoic acid also provoked a marked mitochondrial swelling when either KCl or sucrose was used in the incubation medium and also induced cytochrome c release from mitochondria, suggesting a non-selective permeabilization of the inner mitochondrial membrane. SIGNIFICANCE: It is therefore presumed that impairment of mitochondrial homeostasis provoked by cis-4-decenoic acid may be involved in the brain dysfunction observed in medium-chain acyl-CoA dehydrogenase deficient patients.


Asunto(s)
Encéfalo/efectos de los fármacos , Metabolismo Energético/efectos de los fármacos , Ácidos Grasos Monoinsaturados/toxicidad , Mitocondrias/efectos de los fármacos , Acil-CoA Deshidrogenasa/deficiencia , Animales , Encéfalo/patología , Citocromos c/efectos de los fármacos , Citocromos c/metabolismo , Homeostasis/efectos de los fármacos , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Mitocondrias/metabolismo , Membranas Mitocondriales/efectos de los fármacos , Membranas Mitocondriales/metabolismo , NADP/efectos de los fármacos , NADP/metabolismo , Fosforilación Oxidativa/efectos de los fármacos , Consumo de Oxígeno/efectos de los fármacos , Ratas , Ratas Wistar
3.
East Mediterr Health J ; 15(1): 224-9, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19469447

RESUMEN

The in vitro effects of metronidazole on the production of reactive oxygen species by polymorphonuclear (PMN) cells were studied by means of nitroblue tetrazolium and luminol-dependent chemiluminescence. At therapeutic doses of metronidazole (4.98-24.86 microg/mL) significant inhibition of the production of reactive oxygen species was noted in both methods. The inhibitory effect was in a dose-dependent pattern. The data suggest a scavenging mechanism of metronidazole on reactive oxygen species generated by PMN.


Asunto(s)
Antiinfecciosos/farmacología , Depuradores de Radicales Libres/farmacología , Metronidazol/farmacología , Neutrófilos , Fármacos Sensibilizantes a Radiaciones/farmacología , Especies Reactivas de Oxígeno/antagonistas & inhibidores , Adulto , Aerobiosis/efectos de los fármacos , Aerobiosis/fisiología , Antiinfecciosos/química , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Humanos , Indicadores y Reactivos , Mediciones Luminiscentes , Luminol , Metronidazol/química , Persona de Mediana Edad , NADP/efectos de los fármacos , NADP/fisiología , Neutrófilos/efectos de los fármacos , Neutrófilos/fisiología , Nitroazul de Tetrazolio , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/fisiología , Fagocitosis/efectos de los fármacos , Fagocitosis/fisiología , Fármacos Sensibilizantes a Radiaciones/química , Especies Reactivas de Oxígeno/análisis
4.
Neurochem Int ; 55(6): 362-8, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19375465

RESUMEN

Recent studies have suggested the involvement of secretory phospholipase A2-IIA (sPLA2-IIA) in neuroinflammatory diseases. Although sPLA2-IIA is transcriptionally induced through the NF-kappaB pathway by pro-inflammatory cytokines, whether this induction pathway is affected by other intracellular signaling pathways has not been investigated in detail. In this study, we demonstrated the induction of sPLA2-IIA mRNA and protein expression in astrocytes by cytokines and detected the protein in the culture medium after stimulation. We further investigated the effects of oxidative pathways and botanical antioxidants on the induction pathway and observed that IL-1beta-induced sPLA2-IIA mRNA expression in astrocytes is dependent on ERK1/2 and PI-3 kinase, but not p38 MAPK. In addition to apocynin, a known NADPH oxidase inhibitor, botanical antioxidants, such as resveratrol and epigallocatechin gallate, also inhibited IL-1beta-induced sPLA2-IIA mRNA expression. These compounds also suppressed IL-1beta-induced ERK1/2 activation and translocation of the NADPH oxidase subunit p67 phox from cytosol to membrane fraction. Taken together, these results support the involvement of reactive oxygen species from NADPH oxidase in cytokine induction of sPLA2-IIA in astrocytes and promote the use of botanical antioxidants as protective agents for inhibition of inflammatory responses in these cells.


Asunto(s)
Astrocitos/enzimología , Citocinas/metabolismo , Encefalitis/enzimología , Gliosis/enzimología , Fosfolipasas A2 Grupo II/metabolismo , Estrés Oxidativo/fisiología , Animales , Antioxidantes/farmacología , Línea Celular , Encefalitis/inmunología , Encefalitis/fisiopatología , Gliosis/inmunología , Gliosis/fisiopatología , Fosfolipasas A2 Grupo II/genética , Interleucina-1beta/metabolismo , Interleucina-1beta/farmacología , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Sistema de Señalización de MAP Quinasas/fisiología , NADP/efectos de los fármacos , NADP/metabolismo , Fosfoproteínas/efectos de los fármacos , Fosfoproteínas/metabolismo , Extractos Vegetales/farmacología , ARN Mensajero/efectos de los fármacos , ARN Mensajero/metabolismo , Ratas , Especies Reactivas de Oxígeno/metabolismo
5.
J Med Chem ; 51(7): 2018-26, 2008 Apr 10.
Artículo en Inglés | MEDLINE | ID: mdl-18324763

RESUMEN

Despite presenting bioavailability problems, tea catechins have emerged as promising chemopreventive agents because of their observed efficacy in various animal models. To improve the stability and cellular absorption of tea polyphenols, we developed a new catechin-derived compound, 3- O-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin (TMECG), which has shown significant antiproliferative activity against several cancer cell lines, especially melanoma. The presence of methoxy groups in its ester-bound gallyl moiety drastically decreased its antioxidant and prooxidant properties without affecting its cell-antiproliferative effects, and the data indicated that the 3-gallyl moiety was essential for its biological activity. As regards its action mechanism, we demonstrated that TMECG binds efficiently to human dihydrofolate reductase and down-regulates folate cycle gene expression in melanoma cells. Disruption of the folate cycle by TMECG is a plausible explanation for its observed biological effects and suggests that, like other antifolate compounds, TMECG could be of clinical value in cancer therapy.


Asunto(s)
Antioxidantes/síntesis química , Antioxidantes/farmacología , Catequina/análogos & derivados , Antagonistas del Ácido Fólico/síntesis química , Antagonistas del Ácido Fólico/farmacología , Antioxidantes/química , Catequina/síntesis química , Catequina/química , Catequina/farmacología , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Ensayos de Selección de Medicamentos Antitumorales , Ácido Fólico/efectos de los fármacos , Ácido Fólico/metabolismo , Antagonistas del Ácido Fólico/química , Perfilación de la Expresión Génica , Humanos , Metilenotetrahidrofolato Reductasa (NADPH2)/efectos de los fármacos , Metilenotetrahidrofolato Reductasa (NADPH2)/genética , Modelos Moleculares , Estructura Molecular , NADP/química , NADP/efectos de los fármacos , ARN Mensajero/efectos de los fármacos , ARN Mensajero/genética , Estereoisomerismo , Relación Estructura-Actividad , Té/química , Tetrahidrofolato Deshidrogenasa/efectos de los fármacos , Tetrahidrofolato Deshidrogenasa/genética , Timidilato Sintasa/efectos de los fármacos , Timidilato Sintasa/genética , Factores de Tiempo
6.
Toxicol Ind Health ; 21(9): 231-7, 2005 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16342474

RESUMEN

2,4-Dichlorophenoxyacetic acid (2,4-D), which is a plant auxin analogue, is lethal to broad leaved weeds within days at high dosages and is considered as having low toxicity to mammals. Some studies have reported that exposure to this compound may cause damage to organs such as liver. The aim of this study was to investigate the effects of 2,4-D in mouse liver on chromosomes as well as hexokinase (HK), glucose-6-phosphate dehydrogenase (G6PD), 6-phosphogluconate dehydrogenase (6PGD), lactate dehydrogenase (LDH) and malate dehydrogenase (MDH) which are required for the generation of the pyridine nucleotide pool. The experiments were carried out with a 2,4-D group, an ethanol control for 2,4-D, and saline group for ethanol control group on three generations of mice. Only female parents were given 2,4-D during the gestation period, lactation period and for 33 days following the lactation period. In females of the first cross, 2,4-D caused a significant increase in the activity of LDH, and ethanol alone caused a significant increase in the activities of HK and LDH. In the male offspring of the first cross maternal, 2,4-D caused a significant increase in the activity of LDH, and ethanol alone caused a significant decrease in the activity of 6PGD. In the female offspring of the first cross maternal, ethanol caused a significant increase in the activities of G6PD and MDH. In the female offsprings of the third cross maternal, 2,4-D caused a significant increase in the activity of MDH. No gross morphological changes were observed in internal organs, such as liver, kidney and spleen of the affected animals. Also, a chromosomal study from bone marrow cells indicated no anomalies in chromosomal sets and structures. As a result, 2,4-D had an effect on the first cross maternal and their offsprings. The compound did not affect the parameters studied except MDH enzyme activity in the second and third generation of mice.


Asunto(s)
Ácido 2,4-Diclorofenoxiacético/toxicidad , Herbicidas/toxicidad , Hígado/enzimología , NADP/metabolismo , Oxidorreductasas de Alcohol/efectos de los fármacos , Oxidorreductasas de Alcohol/metabolismo , Animales , Activación Enzimática/efectos de los fármacos , Femenino , Hepatocitos/efectos de los fármacos , Hepatocitos/metabolismo , Hexoquinasa/efectos de los fármacos , Hexoquinasa/metabolismo , Lactancia/efectos de los fármacos , Malato Deshidrogenasa/metabolismo , Masculino , Exposición Materna , Ratones , NADP/efectos de los fármacos , Embarazo
7.
Eksp Klin Farmakol ; 62(3): 50-2, 1999.
Artículo en Ruso | MEDLINE | ID: mdl-10439950

RESUMEN

Experiments on mice with acute toxic damage to the liver induced by thioacetamide (200 mg/kg) demonstrated inhibited activity of enzymes glucose-6-phosphate dehydrogenase (G-6-PDH), NADPH-dependent isocitrate dehydrogenase and malate dehydrogenase in the hepatocyte mitochondrial and microsomal-cytosol fractions. Pharmacotherapy with membranostabilizers and cytochrome P-450 inducers activated the enzymes under study, the degree of activation depended on agents used.


Asunto(s)
Antídotos/uso terapéutico , Enfermedad Hepática Inducida por Sustancias y Drogas/tratamiento farmacológico , Hígado/efectos de los fármacos , NADP/efectos de los fármacos , Enfermedad Aguda , Animales , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Citosol/efectos de los fármacos , Citosol/enzimología , Evaluación Preclínica de Medicamentos , Hígado/citología , Hígado/metabolismo , Masculino , Ratones , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/enzimología , NADP/metabolismo , Tioacetamida/toxicidad , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA